UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040550
Receipt number R000046276
Scientific Title Sugammadex dosing based on ideal or actual body weight in underweight patients
Date of disclosure of the study information 2021/05/27
Last modified on 2021/08/25 16:48:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Sugammadex dosing based on ideal or actual body weight in underweight patients.

Acronym

Sugammadex dosing based on ideal or actual body weight in underweight patients

Scientific Title

Sugammadex dosing based on ideal or actual body weight in underweight patients

Scientific Title:Acronym

Sugammadex dosing based on ideal or actual body weight in underweight patients

Region

Japan


Condition

Condition

Underweight

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine appropriate doses of sugammadex to underweight patients.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Time from sugammadex administration to normarized TOFR=100%.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

doses based on actual body weight

Interventions/Control_2

doses based on ideal body weight

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

BMI below 18.5
ASA-PS= 1-3

Key exclusion criteria

patient who is allergic to muscle relaxants
patient who has neuromuscular diseases
patient who has moderate to severe liver function failure

Target sample size

32


Research contact person

Name of lead principal investigator

1st name Hajime
Middle name
Last name Iwasaki

Organization

Nihon University School of Medicine

Division name

Department of Anesthesiology

Zip code

1738610

Address

30-1, Oyaguchi Kamicho, Itabashi-Ku, Tokyo, Japan

TEL

+81-3-3972-8111

Email

iwasaki.hajime@nihon-u.ac.jp


Public contact

Name of contact person

1st name Hajime
Middle name
Last name Iwasaki

Organization

Nihon University School of Medicine

Division name

Department of Anesthesiology

Zip code

1738610

Address

+81-3-3972-8111

TEL

+81-3-3972-8111

Homepage URL


Email

iwasaki.hajime@nihon-u.ac.jp


Sponsor or person

Institute

Nihon University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Nihon University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nihon University Itabashi Hospital, Clinical Research Judging Committee

Address

30-1, Oyaguchi Kamicho, Itabashi-Ku, Tokyo, Japan

Tel

+81-3-3972-8111

Email

komoda.nozomi@nihon-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

日本大学医学部付属板橋病院(東京都)


Other administrative information

Date of disclosure of the study information

2021 Year 05 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 04 Month 01 Day

Date of IRB

2020 Year 05 Month 22 Day

Anticipated trial start date

2020 Year 05 Month 28 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 05 Month 27 Day

Last modified on

2021 Year 08 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046276


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name